RANCHO CUCAMONGA, CA / ACCESS Newswire / August 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be ...

“This photograph shows me checking microalgae at the TUMCREATE research campus in Singapore. It’s affiliated with several Singaporean organizations, as well as with the Technical University of Munich, ...

Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 4.4% year on year to $174.4 million. Its non-GAAP profit of ...

Primatene MIST, an over-the-counter epinephrine inhalation product, has exceeded the company’s $100 million sales target in 2024, growing consistently since its launch: However, the recent earnings ...

Glucagon injection salesdeclined 25% to $20.6 million in Q2 2025, driven by increased competition and a market shift toward ready-to-use products. Epinephrine salesdecreased 42% to $16.2 million in Q2 ...

AeroPulsR™ generating high concentration aerosols of viscous protein molecules. The drug is loaded easily and aerosolization parameters are entered as prescribed. The LED indicators guide the patients ...